Literature DB >> 19194722

Seroprevalence of influenza A and B in German infants and adolescents.

Andreas Sauerbrei1, R Schmidt-Ott, H Hoyer, P Wutzler.   

Abstract

The objective of this study was to provide seroepidemiological information on influenza A and B antibodies in children and adolescents. Viral immunoglobulin G antibodies were determined retrospectively using enzyme-linked immunosorbent assays in a group of 1,111 children and adolescents. Sera (809) from healthy adult blood donors served as controls. In children, the prevalence of antibodies against influenza A was 82.0% and against influenza B 9.6%, whereas in adults the prevalence of antibodies against influenza A was calculated as 99.4% and against influenza B 56.7%. After decline of maternal antibodies during the first year of life, there was an increase of prevalence of influenza A antibodies up to 100% by the age of 12 years. In contrast, only 1-2% of children up to 9 years had influenza B antibodies increasing to 25% by the age of 18 years and to 70% among adults aged 30 years. Children aged 0-6 years had significantly lower concentrations and >12-15-year-old adolescents had significantly higher concentrations of antibodies against influenza A than adults. For all age groups of children and adolescents, significantly lower antibody concentrations against influenza B were measured in comparison to the blood donor control group. In conclusion, the annual influenza vaccination in children and adolescents may improve considerably the protection against influenza virus infection occurring during epidemics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194722     DOI: 10.1007/s00430-009-0108-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  46 in total

Review 1.  Reduction of the influenza burden in children.

Authors: 
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

2.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

3.  Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004.

Authors:  Daniela Müller; Peter Wutzler; Thomas D Szucs
Journal:  Med Klin (Munich)       Date:  2005-01-15

4.  Coxsackievirus B3 infection in pregnancy and its influence on foetal heart development.

Authors:  A B Lansdown
Journal:  Br J Exp Pathol       Date:  1977-08

5.  Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.

Authors:  E S Hurwitz; M Haber; A Chang; T Shope; S T Teo; J S Giesick; M M Ginsberg; N J Cox
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

6.  The incidence of influenza-associated hospitalizations in children in Germany.

Authors:  J A I Weigl; W Puppe; H J Schmitt
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

Review 7.  Influenza virus infection in infancy and early childhood.

Authors:  Flor M Munoz
Journal:  Paediatr Respir Rev       Date:  2003-06       Impact factor: 2.726

8.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

Authors:  Anthony E Fiore; David K Shay; Penina Haber; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy J Cox
Journal:  MMWR Recomm Rep       Date:  2007-07-13

9.  Congenital malformations and intrauterine growth retardation: a population study.

Authors:  M J Khoury; J D Erickson; J F Cordero; B J McCarthy
Journal:  Pediatrics       Date:  1988-07       Impact factor: 7.124

10.  Will the next human influenza pandemic be caused by the virus of the avian flu A/H5N1? Arguments pro and counter.

Authors:  H W Doerr; Domenica Varwig; Regina Allwinn; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2006-06       Impact factor: 3.402

View more
  21 in total

Review 1.  Recent publications in medical microbiology and immunology: a retrospective.

Authors:  H W Doerr; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

Review 2.  Current knowledge on PB1-F2 of influenza A viruses.

Authors:  Andi Krumbholz; Anja Philipps; Hartmut Oehring; Katja Schwarzer; Annett Eitner; Peter Wutzler; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2010-10-16       Impact factor: 3.402

3.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

5.  Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China.

Authors:  Li Zhang; Wim van der Hoek; Thomas Krafft; Eva Pilot; Liselotte van Asten; Ge Lin; Shuangsheng Wu; Wei Duan; Peng Yang; Quanyi Wang
Journal:  Hum Vaccin Immunother       Date:  2019-11-01       Impact factor: 3.452

6.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.

Authors:  Katelyn M Gostic; Monique Ambrose; Michael Worobey; James O Lloyd-Smith
Journal:  Science       Date:  2016-11-11       Impact factor: 47.728

7.  Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses.

Authors:  Janina Geiler; Martin Michaelis; Patchima Sithisarn; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2010-09-24       Impact factor: 3.402

8.  Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.

Authors:  Undine Ott; Andreas Sauerbrei; Jeannette Lange; Anna Schäfler; Mario Walther; Gunter Wolf; Peter Wutzler; Roland Zell; Andi Krumbholz
Journal:  Med Microbiol Immunol       Date:  2012-02-17       Impact factor: 3.402

9.  Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

Authors:  Regina Allwinn; Janina Geiler; Annemarie Berger; J Cinatl; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2010-02-17       Impact factor: 3.402

10.  How much of virus-specific CD8 T cell reactivity is detected with a peptide pool when compared to individual peptides?

Authors:  Wenji Zhang; Ioana Moldovan; Oleg S Targoni; Ramu A Subbramanian; Paul V Lehmann
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.